Xu Jianli, Wang Lei, Chen Xi, Le Weidong
Institute of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
Front Aging Neurosci. 2022 Jun 22;14:917499. doi: 10.3389/fnagi.2022.917499. eCollection 2022.
Constipation, one of the most common prodromal non-motor symptoms of Parkinson's disease (PD), usually occurs several years earlier than the onset of motor symptoms. Previous studies have shown that constipation occurrence increases as the disease progresses. However, the mechanism underlying this pathologic disorder is not clear yet. Moreover, chronic constipation causes slowness in gastric emptying and, therefore, may lead to a delay in the absorption of medications for PD, including levodopa and dopamine agonists. Accordingly, it is necessary to understand how the pathophysiological factors contribute to constipation during PD as well as pursue precise and effective treatment strategies. In this review, we encapsulate the molecular mechanism of constipation underlying PD and update the progress in the treatments of PD-associated constipation.
便秘是帕金森病(PD)最常见的前驱非运动症状之一,通常比运动症状出现早数年。先前的研究表明,便秘的发生率随着疾病进展而增加。然而,这种病理紊乱的潜在机制尚不清楚。此外,慢性便秘会导致胃排空减慢,因此可能会导致包括左旋多巴和多巴胺激动剂在内的帕金森病药物吸收延迟。因此,有必要了解病理生理因素如何导致帕金森病期间的便秘,并寻求精确有效的治疗策略。在这篇综述中,我们总结了帕金森病便秘的分子机制,并更新了帕金森病相关性便秘治疗的进展。